Pharmazz
Company

Last deal

$7.5M

Amount

Corporate Round

Stage

15.08.2024

Date

4

all rounds

$13.3M

Total amount

General

About Company
Pharmazz is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for critical care medicine.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2010

Number of employees

Company Type

For Profit

Last funding type

Corporate Round

IPO status

Private

Description

The company offers a range of products, including treatments for hypovolemic shock, postoperative pain, cardiac arrest, Alzheimer's disease, ischemic stroke, spinal cord injury, tumor diagnosis, diabetic ketoacidosis, and opioid tolerance. Pharmazz's focus is on providing hospitals with the necessary products for the diagnosis and treatment of clinical conditions that require critical care and hospital settings.
Contacts

Phone number

Social url